Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
0.6589
-0.0021 (-0.32%)
Aug 28, 2026, 9:11 AM EDT - Market open
Artelo Biosciences Market Cap
Artelo Biosciences has a market cap or net worth of $3.03 million as of August 28, 2026. Its market cap has decreased by -52.24% in one year.
Market Cap
3.03M
Enterprise Value
-1.12M
1-Year Change
-52.24%
Ranking
Category
Stock Price
$0.66
ChartMarket Cap Chart
Since November 14, 2017, Artelo Biosciences's market cap has decreased from $5.88M to $3.03M, a decrease of -48.47%. That is a compound annual growth rate of -7.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 3.03M | 22.93% |
| Dec 31, 2025 | 2.46M | -28.01% |
| Dec 31, 2024 | 3.42M | -23.37% |
| Dec 29, 2023 | 4.46M | -45.90% |
| Dec 30, 2022 | 8.25M | -62.41% |
| Dec 31, 2021 | 21.95M | 99.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SciSparc | 3.93M |
| 60 Degrees Pharmaceuticals | 3.87M |
| OSR Health | 3.80M |
| Galmed Pharmaceuticals | 3.64M |
| Calidi Biotherapeutics | 3.53M |
| Valion Bio | 3.42M |
| Genprex | 3.33M |
| Curis | 3.30M |